L-Pampo™, a Novel TLR2/3 Agonist, Acts as a Potent Cancer Vaccine Adjuvant by Activating Draining Lymph Node Dendritic Cells

por Heo, Yoonki, Ko, Eunbyeol, Park, Sejung, Park, Si-On, Ahn, Byung-Cheol, Yum, Jung-Sun, Chun, Eunyoung
Publicado 2023

Association of mannose-binding lectin-2 genotype and serum levels with prognosis of sepsis

por Huh, Jin Won, Song, Kyuyoung, Yum, Jung-Sun, Hong, Sang-Bum, Lim, Chae-Man, Koh, Younsuck
Publicado 2009

Serial Changes in Mannose-Binding Lectin in Patients with Sepsis

por Huh, Jin Won, Song, Kyuyoung, Kim, Hwa Jung, Yum, Jung-Sun, Hong, Sang-Bum, Lim, Chae-Man, Koh, Younsuck
Publicado 2018

Combination of TLR1/2 and TLR3 ligands enhances CD4(+) T cell longevity and antibody responses by modulating type I IFN production

por Lee, Bo Ryeong, Jeong, Soo Kyung, Ahn, Byung Cheol, Lee, Byeong-Jae, Shin, Sung Jae, Yum, Jung Sun, Ha, Sang-Jun
Publicado 2016

COVID-19 Subunit Vaccine with a Combination of TLR1/2 and TLR3 Agonists Induces Robust and Protective Immunity

por Jeong, Soo-Kyung, Heo, Yoon-Ki, Jeong, Jei-Hyun, Ham, Su-Jin, Yum, Jung-Sun, Ahn, Byung-Cheol, Song, Chang-Seon, Chun, Eun-Young
Publicado 2021

Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade

por Lee, Won Suk, Kim, Dong Sung, Kim, Jeong Hun, Heo, Yoonki, Yang, Hannah, Go, Eun-Jin, Kim, Jin Hyoung, Lee, Seung Joon, Ahn, Byung Cheol, Yum, Jung Sun, Chon, Hong Jae, Kim, Chan
Publicado 2022